Hepatitis: Screening and Testing Methods

The development of serological tests for the identification of a counteracting agent to this newly discovered illness has been spurred by the disclosure of hepatitis infection (HV). Intravenous drug users, hemodialysis patients, hemophiliacs, and blood transfusion recipients are among the groups most seriously at risk of becoming infected with HV. The prevalence of post-transfusion hepatitis has significantly decreased because of screening blood donors for HV antagonists. One of the main problems with HV illness is the progression of chronic hepatitis, which can lead to cirrhosis and hepatocellular cancer in 50–60% of cases

 

    Related Conference of Hepatitis: Screening and Testing Methods

    November 21-22, 2024

    23rd World Congress on Gastrointestinal Cancer

    Dubai, UAE
    November 21-22, 2024

    30th World Conference on Gastroenterology & Hepatology

    Dubai, UAE
    March 10-11, 2025

    8th International Congress on Viral Hepatitis

    Paris, France
    March 13-14, 2025

    13th International Conference on Gynecology and Obstetrics

    Prague, Czech Republic
    March 24-25, 2025

    16th International Conference on Liver Diseases & Hepatology

    London, UK
    March 24-25, 2025

    19th World Congress on Gastroenterology -Therapeutics & Hepatology

    Dubai, UAE
    April 14-15, 2025

    25th International Conference on Gastroenterology and Hepatology

    Budapest, Hungary
    June 04-05, 2025

    25th International Conference on Gastroenterology and Hepatology

    Edinburgh, Scotland
    July 30-31, 2025

    4th International Conference on Gastroenterology and Liver

    Paris, France
    August 21-22, 2025

    6th Global Summit on Earth Science and Climate Change

    Aix-en-Provence, France

    Hepatitis: Screening and Testing Methods Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in